Centene Corp is a leading healthcare enterprise that specializes in providing a range of services designed to enhance the quality, accessibility, and affordability of healthcare for individuals and families, particularly those in underserved communities. The company primarily operates within the managed care sector, offering government-sponsored healthcare programs such as Medicaid and Medicare, as well as health insurance marketplace offerings. Centene's commitment to addressing the diverse needs of its members is underscored by its focus on innovative care models, integrated services, and a dedication to improving health outcomes through personalized support and a deep understanding of local health systems.
Shares of insurers and pharmacy benefit manager (PBM) companies such as Centene, Elevance Health, Humana and CVS Health are trading lower Thursday, likely in reaction to UnitedHealth Group's disappointing fourth-quarter 2024 revenue results.
U.S. healthcare spending grew 7.5% to $4.9 trillion in 2023, with hospital care and prescription drugs driving costs. Private insurance accounted for 30% of total spending.
What has Wall Street been buzzing about this week? Here are the top 5 buy calls and the top 5 sell calls made by Wall Street's best analysts during the trading week of Dec. 9-13, 2024.
UnitedHealth stock recovered some lost ground as Wall Street assesses whether the killing of the UnitedHealthcare insurance division CEO will hurt profitability.
Investors closely monitor insider buys, as they can give hints surrounding the long-term picture. Let’s take a closer look at the transactions for those interested in trading like the insiders.
Health insurers face rising costs in Medicare Advantage. Centene and Molina stay profitable by focusing on Medicaid despite high Medical Benefits Ratios.
